1. Glutamate receptor subtypes: promising new pharmacotherapeutic targets

   • Guy A. Higgins
   • Klaus A. Miczek

   Editorial 11 March 2005 Pages: 1 - 3

2. Ionotropic and metabotropic glutamate receptor structure and pharmacology

   • James N. C. Kew
   • John A. Kemp

   Review 25 February 2005 Pages: 4 - 29

   

3. N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives

   • Mark J. Millan

   Review 10 March 2005 Pages: 30 - 53

   

4. Modulators of the glycine site on NMDA receptors, d-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia

   • Tatiana Lipina
   • Viviane Labrie
   • John Roder

   Original Investigation 10 March 2005 Pages: 54 - 67

   

5. Phencyclidine-induced impairment in attention and response control depends on the background genotype of mice: reversal by the mGLU_2/3 receptor agonist LY379268

   • Barbara Greco
   • Roberto W. Invernizzi
   • Mirjana Carli

   Original Investigation 28 January 2005 Pages: 68 - 76

   

6. Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia

   • Alice Egerton
   • Lee Reid
   • Judith A. Pratt

   Original Investigation 29 January 2005 Pages: 77 - 84

   

7. Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat

   • Guy A. Higgins
   • Theresa M. Ballard
   • John A. Kemp

   Original Investigation 10 March 2005 Pages: 85 - 98

   

8. Local glutamate receptor antagonism in the rat prefrontal cortex disrupts response inhibition in a visuospatial attentional task

   • Emily R. Murphy
   • Jeffrey W. Dalley
   • Trevor W. Robbins

   Original Investigation 28 January 2005 Pages: 99 - 107

   

9. Co-activation of glutamate and dopamine receptors within the nucleus accumbens is required for spatial memory consolidation in mice

   • Valentina Ferretti
   • Cédrick Florian
   • Andrea Mele

   Original Investigation 29 January 2005 Pages: 108 - 116

   

10. Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson’s disease

    • Nathalie Turle-Lorenzo
    • Nathalie Breysse
    • Marianne Amalric

    Original Investigation 22 February 2005 Pages: 117 - 127

    

11. Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats

    • E. S. Zakharova
    • W. Danysz
    • A. Y. Bespalov

    Original Investigation 29 January 2005 Pages: 128 - 135

    

12. Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine

    • Hyun-Sang Cho
    • Deepak C. D’Souza
    • John H. Krystal

    Original Investigation 29 January 2005 Pages: 136 - 143

13. A six-month, placebo-controlled trial of d-cycloserine co-administered with conventional antipsychotics in schizophrenia patients

    • Donald C. Goff
    • Lawrence Herz
    • David Schoenfeld

    Original Investigation 21 October 2004 Pages: 144 - 150

    

14. Pouring oil into the fire? On the conundrum of the beneficial effects of NMDA receptor antagonists in Alzheimer disease

    • H. Peter Schmitt

    Commentary 24 December 2004 Pages: 151 - 153

15. Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data

    • Mark D. Black

    Review 26 January 2005 Pages: 154 - 163

16. Effects of deletion of gria1 or gria2 genes encoding glutamatergic AMPA-receptor subunits on place preference conditioning in mice

    • Andy N. Mead
    • Geraldine Brown
    • David N. Stephens

    Original Investigation 24 December 2004 Pages: 164 - 171

    

17. Repeated administration of AMPA or a metabotropic glutamate receptor agonist into the rat ventral tegmental area augments the subsequent behavioral hyperactivity induced by cocaine

    • Justin M. Dunn
    • Brian R. Inderwies
    • R. Christopher Pierce

    Original Investigation 04 December 2004 Pages: 172 - 180

    

18. Locomotor activity detects subunit-selective effects of agonists and decahydroisoquinoline antagonists at AMPA/kainic acid ionotropic glutamate receptors in adult rats

    • Michael F. O’Neill
    • Graham Sanger
    • Sandra M. Woodhouse

    Original Investigation 26 January 2005 Pages: 181 - 188

    

19. NMDA or AMPA/kainate receptor blockade prevents acquisition of conditioned place preference induced by D_2/3 dopamine receptor stimulation in rats

    • Anna-Maria Biondo
    • Robert L. H. Clements
    • Andrew J. Greenshaw

    Original Investigation 03 March 2005 Pages: 189 - 197

    

20. Effects of mGlu1 receptor blockade on anxiety-related behaviour in the rat lick suppression test

    • Thomas Steckler
    • Hilde Lavreysen
    • Anne S. J. Lesage

    Original Investigation 04 December 2004 Pages: 198 - 206

    

21. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles

    • Geoffrey B. Varty
    • Mariagrazia Grilli
    • Rosalia Bertorelli

    Original Investigation 29 January 2005 Pages: 207 - 217

    

22. The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison

    • Theresa M. Ballard
    • Marie L. Woolley
    • Will Spooren

    Original Investigation 01 March 2005 Pages: 218 - 229

    

23. Behavioral sensitization due to social defeat stress in mice: antagonism at mGluR5 and NMDA receptors

    • Jasmine J. Yap
    • Herbert E. Covington III
    • Klaus A. Miczek

    Original Investigation 23 October 2004 Pages: 230 - 239

    

24. Blockade of the mGlu5 receptor decreases basal and stress-induced cortical norepinephrine in rodents

    • Michelle E. Page
    • Paul Szeliga
    • John F. Cryan

    Original Investigation 17 February 2005 Pages: 240 - 246

    

25. Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats

    • Paul J. Kenny
    • Benjamin Boutrel
    • Athina Markou

    Original Investigation 16 December 2004 Pages: 247 - 254

    

26. The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats

    • Neil E. Paterson
    • Athina Markou

    Original Investigation 24 December 2004 Pages: 255 - 261

    

27. The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats

    • Jason P. Schroeder
    • David H. Overstreet
    • Clyde W. Hodge

    Original Investigation 17 February 2005 Pages: 262 - 270

    

28. Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s)

    • Michael P. Johnson
    • David Barda
    • Darryle D. Schoepp

    Original Investigation 17 February 2005 Pages: 271 - 283

    

29. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice

    • A.-M. Linden
    • H. Shannon
    • D. D. Schoepp

    Original Investigation 24 December 2004 Pages: 284 - 291

    

30. Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys

    • Simona Spinelli
    • Theresa Ballard
    • Christopher R. Pryce

    Original Investigation 28 January 2005 Pages: 292 - 302

    

31. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

    • John H. Krystal
    • Walid Abi-Saab
    • Alan Breier

    Original Investigation 10 August 2004 Pages: 303 - 309

    

32. Effects of a metabotropic glutamate_2/3 receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results

    • Michael Kellner
    • Christoph Muhtz
    • Klaus Wiedemann

    Original Investigation 30 September 2004 Pages: 310 - 315